Cite
MLA Citation
K.S. Boye et al.. “IDF21-0018 Patient Reported Outcomes for Tirzepatide versus Semaglutide in Participants with T2D from the SURPASS-2 Trial.” Diabetes research and clinical practice, vol. 186, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100156437780.0x000046